![]() ARTIVION CryoLife is a company engaged in the manufacturing, processing, and distribution of medical devices and implantable human tissues used in cardiac and vascular surgical procedures focused on aortic repair. | ![]() Glaukos Glaukos is an ophthalmic medical technology and pharmaceutical company that develops therapies for treating glaucoma, corneal disorders, and retinal diseases. | ||
Founding Date | Founding Date 1971 | Founding Date 1984 | Founding Date 1998 |
Type | Type Public | Type Public | Type Public |
Tags | |||
Locations | Locations Kennesaw, US HQ Paris, FR Singapore, SG Guildford, GB Austin, US | Locations Aliso Viejo, US HQ Buenos Aires, AR Heatherton, AU Sao Paulo, BR Richmond Hill, CA San José, CR Wiesbaden, DE see more | |
Employees | Employees 3,65721% increase | Employees 1,2009% increase | Employees 90716% increase |
Valuation ($) | Valuation ($) 3.7 b | Valuation ($) 1.1 b | Valuation ($) 7.6 b |
Financial | |||
Revenue (est.) | Revenue (est.) $1.3b (FY, 2026) | Revenue (est.) $441.3m (FY, 2025) | Revenue (est.) $507.4m (FY, 2025) |
Cost of goods | Cost of goods $546.4m (FY, 2026) | Cost of goods $157.1m (FY, 2025) | Cost of goods $111.8m (FY, 2025) |
Gross profit | Gross profit $787.6m (FY, 2026) | Gross profit $284.2m (FY, 2025) | Gross profit $282.8m (FY, 2025) |
Net income | Net income $97.3m (FY, 2026) | Net income $9.8m (FY, 2025) | Net income ($187.7m) (FY, 2025) |
Operating ⚠ | |||
Facility Space Leased, sq. ft. | Facility Space Leased, sq. ft. 885.4 k (FY, 2023) | Facility Space Leased, sq. ft. N/A | Facility Space Leased, sq. ft. 318 k (FY, 2022) |
Funding | |||
Total funding raised | Total funding raised N/A | Total funding raised $ 1.3m | Total funding raised $ 115m |

CryoLife is a company engaged in the manufacturing, processing, and distribution of medical devices and implantable human tissues used in cardiac and vascular surgical procedures focused on aortic repair.
View company
Glaukos is an ophthalmic medical technology and pharmaceutical company that develops therapies for treating glaucoma, corneal disorders, and retinal diseases.
View company